2016_Head & Neck COURSE BOOK

On-going validation studies

IAEA-HypoX • Randomized phase III; accelerated radiotherapy ± Nimorazole – hypoxia gene expression and HPV/p16 – Eastern Europe, Asia – Recruitment opened 2012 Intergroup EORTC - ROG HNCG 1219 DAHANCA • Randomized phase III; accelerated chemoradiotherapy ± Nimorazole – hypoxia gene expression and HPV/p16 – Europe, Canada – Recruitment starting 2013

www.azanta.com